カテゴリー： Market Monitor Global, 世界, 医療/バイオ

不活化ポリオウイルスワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Poliovirus Vaccine Inactivated Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8572 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：77 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Poliovirus Vaccine Inactivated Market 調査レポートは次の情報を含め、グローバルにおけるの不活化ポリオウイルスワクチン市場規模と予測を収録しています。・世界の不活化ポリオウイルスワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の不活化ポリオウイルスワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の不活化ポリオウイルスワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ヒト二倍体細胞」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

不活化ポリオウイルスワクチンのグローバル主要企業は、Sanofi、 GSK、 Serum Institute (Bilthoven Biologicals)、 IMBCAなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、不活化ポリオウイルスワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の不活化ポリオウイルスワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の不活化ポリオウイルスワクチン市場：タイプ別市場シェア、2022年
・ヒト二倍体細胞、サル腎臓細胞

世界の不活化ポリオウイルスワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の不活化ポリオウイルスワクチン市場：用途別市場シェア、2022年
・公共、民間

世界の不活化ポリオウイルスワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の不活化ポリオウイルスワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における不活化ポリオウイルスワクチンのグローバル売上、2018年-2023年
・主要企業における不活化ポリオウイルスワクチンのグローバル売上シェア、2022年
・主要企業における不活化ポリオウイルスワクチンのグローバル販売量、2018年-2023年
・主要企業における不活化ポリオウイルスワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi、 GSK、 Serum Institute (Bilthoven Biologicals)、 IMBCA

*************************************************************

・調査・分析レポートの概要
不活化ポリオウイルスワクチン市場の定義
市場セグメント
世界の不活化ポリオウイルスワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の不活化ポリオウイルスワクチン市場規模
世界の不活化ポリオウイルスワクチン市場規模：2022年 VS 2029年
世界の不活化ポリオウイルスワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの不活化ポリオウイルスワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の不活化ポリオウイルスワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ヒト二倍体細胞、サル腎臓細胞
不活化ポリオウイルスワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：公共、民間
不活化ポリオウイルスワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別不活化ポリオウイルスワクチン市場規模 2022年と2029年
地域別不活化ポリオウイルスワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 GSK、 Serum Institute (Bilthoven Biologicals)、 IMBCA
...

Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.
This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine Inactivated, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine Inactivated. This report contains market size and forecasts of Poliovirus Vaccine Inactivated in global, including the following market information:
Global Poliovirus Vaccine Inactivated Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Poliovirus Vaccine Inactivated Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Poliovirus Vaccine Inactivated companies in 2022 (%)
The global Poliovirus Vaccine Inactivated market was valued at US$ 730.3 million in 2022 and is projected to reach US$ 957.4 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Human Diploid Cell Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Poliovirus Vaccine Inactivated include Sanofi, GSK, Serum Institute (Bilthoven Biologicals) and IMBCA, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Poliovirus Vaccine Inactivated manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Poliovirus Vaccine Inactivated Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliovirus Vaccine Inactivated Market Segment Percentages, by Type, 2022 (%)
Human Diploid Cell
Monkey Kidney Cell
Global Poliovirus Vaccine Inactivated Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliovirus Vaccine Inactivated Market Segment Percentages, by Application, 2022 (%)
Public
Private
Global Poliovirus Vaccine Inactivated Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliovirus Vaccine Inactivated Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Poliovirus Vaccine Inactivated revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Poliovirus Vaccine Inactivated revenues share in global market, 2022 (%)
Key companies Poliovirus Vaccine Inactivated sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Poliovirus Vaccine Inactivated sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Poliovirus Vaccine Inactivated, market overview.
Chapter 2: Global Poliovirus Vaccine Inactivated market size in revenue and volume.
Chapter 3: Detailed analysis of Poliovirus Vaccine Inactivated manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Poliovirus Vaccine Inactivated in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Poliovirus Vaccine Inactivated capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Poliovirus Vaccine Inactivated Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Poliovirus Vaccine Inactivated Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Poliovirus Vaccine Inactivated Overall Market Size
2.1 Global Poliovirus Vaccine Inactivated Market Size: 2022 VS 2029
2.2 Global Poliovirus Vaccine Inactivated Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Poliovirus Vaccine Inactivated Sales: 2018-2029
3 Company Landscape
3.1 Top Poliovirus Vaccine Inactivated Players in Global Market
3.2 Top Global Poliovirus Vaccine Inactivated Companies Ranked by Revenue
3.3 Global Poliovirus Vaccine Inactivated Revenue by Companies
3.4 Global Poliovirus Vaccine Inactivated Sales by Companies
3.5 Global Poliovirus Vaccine Inactivated Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Poliovirus Vaccine Inactivated Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Poliovirus Vaccine Inactivated Product Type
3.8 Tier 1, Tier 2 and Tier 3 Poliovirus Vaccine Inactivated Players in Global Market
3.8.1 List of Global Tier 1 Poliovirus Vaccine Inactivated Companies
3.8.2 List of Global Tier 2 and Tier 3 Poliovirus Vaccine Inactivated Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Poliovirus Vaccine Inactivated Market Size Markets, 2022 & 2029
4.1.2 Human Diploid Cell
4.1.3 Monkey Kidney Cell
4.2 By Type – Global Poliovirus Vaccine Inactivated Revenue & Forecasts
4.2.1 By Type – Global Poliovirus Vaccine Inactivated Revenue, 2018-2023
4.2.2 By Type – Global Poliovirus Vaccine Inactivated Revenue, 2024-2029
4.2.3 By Type – Global Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
4.3 By Type – Global Poliovirus Vaccine Inactivated Sales & Forecasts
4.3.1 By Type – Global Poliovirus Vaccine Inactivated Sales, 2018-2023
4.3.2 By Type – Global Poliovirus Vaccine Inactivated Sales, 2024-2029
4.3.3 By Type – Global Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
4.4 By Type – Global Poliovirus Vaccine Inactivated Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Poliovirus Vaccine Inactivated Market Size, 2022 & 2029
5.1.2 Public
5.1.3 Private
5.2 By Application – Global Poliovirus Vaccine Inactivated Revenue & Forecasts
5.2.1 By Application – Global Poliovirus Vaccine Inactivated Revenue, 2018-2023
5.2.2 By Application – Global Poliovirus Vaccine Inactivated Revenue, 2024-2029
5.2.3 By Application – Global Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
5.3 By Application – Global Poliovirus Vaccine Inactivated Sales & Forecasts
5.3.1 By Application – Global Poliovirus Vaccine Inactivated Sales, 2018-2023
5.3.2 By Application – Global Poliovirus Vaccine Inactivated Sales, 2024-2029
5.3.3 By Application – Global Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
5.4 By Application – Global Poliovirus Vaccine Inactivated Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Poliovirus Vaccine Inactivated Market Size, 2022 & 2029
6.2 By Region – Global Poliovirus Vaccine Inactivated Revenue & Forecasts
6.2.1 By Region – Global Poliovirus Vaccine Inactivated Revenue, 2018-2023
6.2.2 By Region – Global Poliovirus Vaccine Inactivated Revenue, 2024-2029
6.2.3 By Region – Global Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
6.3 By Region – Global Poliovirus Vaccine Inactivated Sales & Forecasts
6.3.1 By Region – Global Poliovirus Vaccine Inactivated Sales, 2018-2023
6.3.2 By Region – Global Poliovirus Vaccine Inactivated Sales, 2024-2029
6.3.3 By Region – Global Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Poliovirus Vaccine Inactivated Revenue, 2018-2029
6.4.2 By Country – North America Poliovirus Vaccine Inactivated Sales, 2018-2029
6.4.3 US Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.4.4 Canada Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.4.5 Mexico Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Poliovirus Vaccine Inactivated Revenue, 2018-2029
6.5.2 By Country – Europe Poliovirus Vaccine Inactivated Sales, 2018-2029
6.5.3 Germany Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.5.4 France Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.5.5 U.K. Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.5.6 Italy Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.5.7 Russia Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.5.8 Nordic Countries Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.5.9 Benelux Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Poliovirus Vaccine Inactivated Revenue, 2018-2029
6.6.2 By Region – Asia Poliovirus Vaccine Inactivated Sales, 2018-2029
6.6.3 China Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.6.4 Japan Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.6.5 South Korea Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.6.6 Southeast Asia Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.6.7 India Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Poliovirus Vaccine Inactivated Revenue, 2018-2029
6.7.2 By Country – South America Poliovirus Vaccine Inactivated Sales, 2018-2029
6.7.3 Brazil Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.7.4 Argentina Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Poliovirus Vaccine Inactivated Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Poliovirus Vaccine Inactivated Sales, 2018-2029
6.8.3 Turkey Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.8.4 Israel Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.8.5 Saudi Arabia Poliovirus Vaccine Inactivated Market Size, 2018-2029
6.8.6 UAE Poliovirus Vaccine Inactivated Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Poliovirus Vaccine Inactivated Major Product Offerings
7.1.4 Sanofi Poliovirus Vaccine Inactivated Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Poliovirus Vaccine Inactivated Major Product Offerings
7.2.4 GSK Poliovirus Vaccine Inactivated Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Serum Institute (Bilthoven Biologicals)
7.3.1 Serum Institute (Bilthoven Biologicals) Company Summary
7.3.2 Serum Institute (Bilthoven Biologicals) Business Overview
7.3.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Major Product Offerings
7.3.4 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales and Revenue in Global (2018-2023)
7.3.5 Serum Institute (Bilthoven Biologicals) Key News & Latest Developments
7.4 IMBCA
7.4.1 IMBCA Company Summary
7.4.2 IMBCA Business Overview
7.4.3 IMBCA Poliovirus Vaccine Inactivated Major Product Offerings
7.4.4 IMBCA Poliovirus Vaccine Inactivated Sales and Revenue in Global (2018-2023)
7.4.5 IMBCA Key News & Latest Developments
8 Global Poliovirus Vaccine Inactivated Production Capacity, Analysis
8.1 Global Poliovirus Vaccine Inactivated Production Capacity, 2018-2029
8.2 Poliovirus Vaccine Inactivated Production Capacity of Key Manufacturers in Global Market
8.3 Global Poliovirus Vaccine Inactivated Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Poliovirus Vaccine Inactivated Supply Chain Analysis
10.1 Poliovirus Vaccine Inactivated Industry Value Chain
10.2 Poliovirus Vaccine Inactivated Upstream Market
10.3 Poliovirus Vaccine Inactivated Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Poliovirus Vaccine Inactivated Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Poliovirus Vaccine Inactivated in Global Market
Table 2. Top Poliovirus Vaccine Inactivated Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Poliovirus Vaccine Inactivated Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Poliovirus Vaccine Inactivated Revenue Share by Companies, 2018-2023
Table 5. Global Poliovirus Vaccine Inactivated Sales by Companies, (K Units), 2018-2023
Table 6. Global Poliovirus Vaccine Inactivated Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Poliovirus Vaccine Inactivated Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Poliovirus Vaccine Inactivated Product Type
Table 9. List of Global Tier 1 Poliovirus Vaccine Inactivated Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Poliovirus Vaccine Inactivated Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Poliovirus Vaccine Inactivated Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Poliovirus Vaccine Inactivated Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Poliovirus Vaccine Inactivated Sales (K Units), 2018-2023
Table 15. By Type - Global Poliovirus Vaccine Inactivated Sales (K Units), 2024-2029
Table 16. By Application – Global Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Poliovirus Vaccine Inactivated Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Poliovirus Vaccine Inactivated Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Poliovirus Vaccine Inactivated Sales (K Units), 2018-2023
Table 20. By Application - Global Poliovirus Vaccine Inactivated Sales (K Units), 2024-2029
Table 21. By Region – Global Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Poliovirus Vaccine Inactivated Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Poliovirus Vaccine Inactivated Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Poliovirus Vaccine Inactivated Sales (K Units), 2018-2023
Table 25. By Region - Global Poliovirus Vaccine Inactivated Sales (K Units), 2024-2029
Table 26. By Country - North America Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Poliovirus Vaccine Inactivated Sales, (K Units), 2018-2023
Table 29. By Country - North America Poliovirus Vaccine Inactivated Sales, (K Units), 2024-2029
Table 30. By Country - Europe Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Poliovirus Vaccine Inactivated Sales, (K Units), 2018-2023
Table 33. By Country - Europe Poliovirus Vaccine Inactivated Sales, (K Units), 2024-2029
Table 34. By Region - Asia Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Poliovirus Vaccine Inactivated Sales, (K Units), 2018-2023
Table 37. By Region - Asia Poliovirus Vaccine Inactivated Sales, (K Units), 2024-2029
Table 38. By Country - South America Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Poliovirus Vaccine Inactivated Sales, (K Units), 2018-2023
Table 41. By Country - South America Poliovirus Vaccine Inactivated Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Poliovirus Vaccine Inactivated Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Poliovirus Vaccine Inactivated Sales, (K Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Poliovirus Vaccine Inactivated Product Offerings
Table 48. Sanofi Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Poliovirus Vaccine Inactivated Product Offerings
Table 52. GSK Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Serum Institute (Bilthoven Biologicals) Company Summary
Table 55. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Offerings
Table 56. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Serum Institute (Bilthoven Biologicals) Key News & Latest Developments
Table 58. IMBCA Company Summary
Table 59. IMBCA Poliovirus Vaccine Inactivated Product Offerings
Table 60. IMBCA Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. IMBCA Key News & Latest Developments
Table 62. Poliovirus Vaccine Inactivated Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 63. Global Poliovirus Vaccine Inactivated Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Poliovirus Vaccine Inactivated Production by Region, 2018-2023 (K Units)
Table 65. Global Poliovirus Vaccine Inactivated Production by Region, 2024-2029 (K Units)
Table 66. Poliovirus Vaccine Inactivated Market Opportunities & Trends in Global Market
Table 67. Poliovirus Vaccine Inactivated Market Drivers in Global Market
Table 68. Poliovirus Vaccine Inactivated Market Restraints in Global Market
Table 69. Poliovirus Vaccine Inactivated Raw Materials
Table 70. Poliovirus Vaccine Inactivated Raw Materials Suppliers in Global Market
Table 71. Typical Poliovirus Vaccine Inactivated Downstream
Table 72. Poliovirus Vaccine Inactivated Downstream Clients in Global Market
Table 73. Poliovirus Vaccine Inactivated Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Poliovirus Vaccine Inactivated Segment by Type in 2022
Figure 2. Poliovirus Vaccine Inactivated Segment by Application in 2022
Figure 3. Global Poliovirus Vaccine Inactivated Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Poliovirus Vaccine Inactivated Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Poliovirus Vaccine Inactivated Revenue, 2018-2029 (US$, Mn)
Figure 7. Poliovirus Vaccine Inactivated Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Poliovirus Vaccine Inactivated Revenue in 2022
Figure 9. By Type - Global Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
Figure 11. By Type - Global Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
Figure 12. By Type - Global Poliovirus Vaccine Inactivated Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
Figure 15. By Application - Global Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
Figure 16. By Application - Global Poliovirus Vaccine Inactivated Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Poliovirus Vaccine Inactivated Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
Figure 20. By Region - Global Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
Figure 21. By Country - North America Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
Figure 22. By Country - North America Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
Figure 23. US Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
Figure 28. Germany Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 29. France Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
Figure 37. China Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 41. India Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
Figure 43. By Country - South America Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
Figure 44. Brazil Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Poliovirus Vaccine Inactivated Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Poliovirus Vaccine Inactivated Sales Market Share, 2018-2029
Figure 48. Turkey Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Poliovirus Vaccine Inactivated Revenue, (US$, Mn), 2018-2029
Figure 52. Global Poliovirus Vaccine Inactivated Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Poliovirus Vaccine Inactivated by Region, 2022 VS 2029
Figure 54. Poliovirus Vaccine Inactivated Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 不活化ポリオウイルスワクチンの世界市場見通し2023年-2029年(Poliovirus Vaccine Inactivated Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

不活化ポリオウイルスワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp